Money · Lobbying reports · 119th Congress
S. 2276
23 saved lobbying reports name S. 2276.
23 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read November 22, 2026 at 12:34 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| SANOFI US SERVICES INC. | SANOFI US SERVICES INC | $1,250,000.00reported as expenses | July to September 2026 | Open the report | |
| PUBLIC CITIZEN | PUBLIC CITIZEN | $133,000.00reported as expenses | July to September 2026 | Open the report | |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $2,560,000.00reported as expenses | July to September 2026 | Open the report | |
| RADIUS ADVOCACY, LLC | COUNCIL FOR INNOVATION PROMOTION (C4IP) | $50,000.00reported as income | July to September 2026 | Open the report | |
| WILEY REIN LLP | FRESENIUS KABI USA LLC | $10,000.00reported as income | July to September 2026 | Open the report | |
| FAMILIES USA FOUNDATION, INC. | FAMILIES USA FOUNDATION INC | $30,000.00reported as expenses | July to September 2026 | Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,040,000.00reported as expenses | July to September 2026 | Open the report | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $1,530,000.00reported as expenses | July to September 2026 | Open the report | |
| BAYER CORPORATION (CONSOLIDATED REPORT) | BAYER CORPORATION (CONSOLIDATED REPORT) | $1,710,000.00reported as expenses | July to September 2026 | Open the report | |
| AMGEN, INC. | AMGEN INC | $3,150,000.00reported as expenses | July to September 2026 | Open the report | |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $2,220,000.00reported as expenses | July to September 2026 | Open the report | |
| NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS) | NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS) | $1,910,000.00reported as expenses | July to September 2026 | Open the report | |
| NOVARTIS | NOVARTIS | $840,000.00reported as expenses | July to September 2026 | Open the report | |
| FRESENIUS KABI USA LLC | FRESENIUS KABI USA LLC | $630,000.00reported as expenses | July to September 2026 | Open the report | |
| COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | $90,000.00reported as expenses | July to September 2026 | Open the report | |
| CHAMBER OF COMMERCE OF THE U.S.A. | CHAMBER OF COMMERCE OF THE U.S.A. | $16,480,000.00reported as expenses | July to September 2026 | Open the report | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $3,203,049.00reported as expenses | July to September 2026 | Open the report | |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90,000.00reported as income | July to September 2026 | Open the report | |
| AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) | AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) | $10,000.00reported as expenses | July to September 2026 | Open the report | |
| ASSOCIATION FOR ACCESSIBLE MEDICINES | ASSOCIATION FOR ACCESSIBLE MEDICINES | $770,000.00reported as expenses | July to September 2026 | Open the report | |
| KAISER FOUNDATION HEALTH PLAN INC. | KAISER FOUNDATION HEALTH PLAN INC | $500,000.00reported as expenses | July to September 2026 | Open the report | |
| S-3 GROUP | FRESENIUS KABI | $30,000.00reported as income | July to September 2026 | Open the report | |
| T1INTERNATIONAL USA | T1INTERNATIONAL USA | The report gives no amount | July to September 2026 | Open the report |